相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and biological evaluation of novel phthalazinone acridine derivatives as dual PARP and Topo inhibitors for potential anticancer agents
Qiuzi Dai et al.
CHINESE CHEMICAL LETTERS (2020)
Synthesis and vasodilator activity of some pyridazin-3(2H)-one based compounds
Heba Abdelrasheed Allam et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Meeting organometallic chemistry with drug discovery: C-H activation enabled discovery of a new ring system of 12H-Indazolo[2,1-a]cinnolin-12-ones with anti-proliferation activity
Xiang Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation
Eman M. Ahmed et al.
BIOORGANIC CHEMISTRY (2020)
Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma
Yun Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy
Junwei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis, crystal structures and biological evaluation of new pyridazine derivatives
Bholey Singh et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
Synthetic Sphingolipids with 1,2-Pyridazine Appendages Improve Antiproliferative Activity in Human Cancer Cell Lines
Sylvestre P. J. T. Bachollet et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitors
Abida Khan et al.
DRUG DEVELOPMENT RESEARCH (2020)
Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM-833 [(R)-N-(pyridazin-3-yl)-4-(7-(trifluoromethyl)chroman-4-yl)piperazine-1-carboxamide] in rats: Potential for the treatment of inflammatory pain
Toshiya Endo et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Synthesis of new oxadiazol-phthalazinone derivatives with anti-proliferative activity; molecular docking, pro-apoptotic, and enzyme inhibition profile
Mohamed H. Hekal et al.
RSC ADVANCES (2020)
Synthesis and Biological Activity of Pyridopyridazine Derivatives: A Mini Review
Anna Wojcicka et al.
MINI-REVIEWS IN ORGANIC CHEMISTRY (2019)
Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold
Ghada F. Elmasry et al.
BIOORGANIC CHEMISTRY (2019)
A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation
Denisse A. Gutierrez et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents
Yunlei Hou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1-a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links
Sue-Ming Chang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis, characterization, and antidiabetic activity of 6-methoxyimidazo[1,2-b]pyridazine derivatives
Tata Veereswara Rao Kota et al.
JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2019)
SYNTHESIS OF NEW 6-[4-(2-FLUOROPHENYLPIPERAZINE-1-YL)]-3(2H)-PYRIDAZINONE-2-ACETHYL-2-(SUBSTITUTEDBENZAL)HYDRAZONE DERIVATIVES AND EVULATION OF THEIR CYTOTOXIC EFFECTS IN LIVER AND COLON CANCER CELL LINES
Zeynep Ozdemir et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2019)
Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors
Chunjian Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity
Toru Taniguchi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
In vitro anti-proliferative and in silico docking studies of heteroleptic copper(II) complexes of pyridazine-based ligands and ciprofloxacin
U. Muhammed Rafi et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2019)
Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators
Takashi Tsuji et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Design and synthesis of new phthalazine-based derivatives as potential EGFR inhibitors for the treatment of hepatocellular carcinoma
Ahmed T. A. Boraei et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis and bioevaluation of 6-chloropyridazin-3-yl hydrazones and 6-chloro-3-substituted-[1,2,4]triazolo[4,3-b] pyridazines as cytotoxic agents
Mamta et al.
BIOORGANIC CHEMISTRY (2019)
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
Sonia Martinez-Gonzalez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis
Jing-Mei Yuan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Isomeric platinum organometallics derived from pyrimidine, pyridazine or pyrazine and their potential as antitumor drugs
Khushwant Singh et al.
INORGANICA CHIMICA ACTA (2019)
Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design
Yulan Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models
M. Raymond V. Finlay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review
Jaiprakash Sangshetti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Design, Synthesis, and Pharmacological Assay of Novel Compounds Based on Pyridazine Moiety as Potential Antitumor Agents
Yasmeen M. Ali et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2019)
Synthesis of new annulated pyridazine derivatives and studying their antioxidant and antimicrobial activities
Heba E. Hashem et al.
SYNTHETIC COMMUNICATIONS (2019)
Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase
Daniel P. O'Malley et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Triazolopyridazine derivatives: Synthesis, cytotoxic evaluation, c-Met kinase activity and molecular docking
Eman M. Ahmed et al.
BIOORGANIC CHEMISTRY (2019)
Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors
Xi Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model
Maolin Yu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Virtual screening in drug-likeness and structure/activity relationship of pyridazine derivatives as Anti-Alzheimer drugs
Anfel Zerroug et al.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2019)
AMulticenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors
Eric Van Cutsem et al.
CLINICAL CANCER RESEARCH (2019)
Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors
Cheng-Zhi Gao et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives
Lacramioara Popovici et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
Salwa Elmeligie et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation
Vegard Torp Lien et al.
RSC ADVANCES (2019)
Induction of apoptosis by pyrazolo[3,4-d]pyridazine derivative in lung cancer cells via disruption of Bcl-2/Bax expression balance
Mervat S. Mohamed et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Synthesis and biological evaluation of 2,4-disubstituted phthalazinones as Aurora kinase inhibitors
Wei Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors
Zilun Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Novel pyrrol-2(3H)-ones and pyridazin-3(2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors
Mahmoud S. Abdelbaset et al.
BIOORGANIC CHEMISTRY (2018)
Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer
Hadia Almahli et al.
BIOORGANIC CHEMISTRY (2018)
Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State
Anneleen Daemen et al.
CELL METABOLISM (2018)
Synthesis and Antitumor Activity of 1-Phenyl-4-substituted Phthalazine Derivatives
Jingchao Xin et al.
CHINESE JOURNAL OF ORGANIC CHEMISTRY (2018)
Synthesis of -(Trifluoromethyl)pyridazine Derivatives
Alexandra Feraldi-Xypolia et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2018)
Pyridazine-based heteroleptic copper(II) complexes as potent anticancer drugs by inducing apoptosis and S-phase arrest in breast cancer cell
Ummer Muhammed Rafi et al.
INORGANICA CHIMICA ACTA (2018)
Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity
Sean W. Reilly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis of New Isoxazole-, Pyridazine-, Pyrimidopyrazines and their Anti-Inflammatory and Analgesic Activity
Ameen A. Abu-Hashem et al.
MEDICINAL CHEMISTRY (2018)
Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents
Wasim Akhtar et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors
Xiaobo Liu et al.
MOLECULES (2018)
In Vitro Antitumor Activity of Newly Synthesized Pyridazin-3(2H)-One Derivatives via Apoptosis Induction
Najat Bouchmaa et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2018)
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors
Bernard Barlaam et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Design and Synthesis of Novel 3-(2-Aminopyridin-3-yl)-1,2,4-Triazolo [4,3-b]Pyridazine Derivatives as a Reversible Bruton's Tyrosine Kinase Inhibitors
Chi Hoon Park et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2018)
New 1-phthalazinone Scaffold based Compounds: Design, Synthesis, Cytotoxicity and Protein Kinase Inhibition Activity
Nehad E. Abo-elmagd et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Cytotoxicity of new pyridazin-3(2H)-one derivatives orchestrating oxidative stress in human triple-negative breast cancer (MDA-MB-468)
Najat Bouchmaa et al.
ARCHIV DER PHARMAZIE (2018)
Click Synthesis, Anticancer Activity and Molecular Docking Studies on Pyridazinone Scaffolds
Tamer El Malah et al.
CURRENT ORGANIC CHEMISTRY (2018)
Altering Nitrogen Heterocycles of AZD2461 Affords High Affinity Poly(ADP-ribose) Polymerase-1 Inhibitors with Decreased P-Glycoprotein Interactions
Sean W. Reilly et al.
ACS OMEGA (2018)
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
Ann-Gerd Thorsell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine derivatives as mTOR inhibitors
Beibei Mao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of novel 7-azaindole derivatives bearing dihydropyridazine moiety as c-Met kinase inhibitors
Qidong Tang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and biological evaluation of substituted aminopyridazin-3(2H)-ones as G0/G1-phase arresting agents with apoptosis-inducing activities
Bing-Chen Ge et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors
Lin Xiao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
Ankit C. Borisa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents
Wagdy M. Eldehn et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis of Novel Phthalazine Derivatives as Potential Anticancer and Antioxidant Agents Based on 1-Chloro-4-(4-phenoxyphenyl)phthalazine
Mohamed S. Behalo et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2017)
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors
Sabin Llona-Minguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and Anticancer Studies of Novel N-benzyl Pyridazino ne Derivatives
Mohamed Elagawany et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2017)
Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives
Dong Lu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Synthesis and Evaluation of Novel 3-Allylseleno-6-Alkylsulfonylpyridazine Derivatives with Potential Anticancer Properties
Chaewon Kim et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2017)
Recent Advances in the Synthesis of Biologically Active Cinnoline, Phthalazine and Quinoxaline Derivatives
Young Taek Han et al.
CURRENT ORGANIC CHEMISTRY (2017)
The anti-invasive role of novel synthesized pyridazine hydrazide appended phenoxy acetic acid against neoplastic development targeting matrix metallo proteases
Yasser Hussein Eissa Mohammed et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor
Timothy R. L. Howes et al.
DNA REPAIR (2017)
Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR-2 Inhibitors
Abdel-Ghany A. El-Helby et al.
ARCHIV DER PHARMAZIE (2017)
FGFR a promising druggable target in cancer: Molecular biology and new drugs
Rut Porta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Pyridazine Based Scaffolds as Privileged Structures in anti-Cancer Therapy
Maiy Youssef Jaballah et al.
DRUG RESEARCH (2017)
Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors
Eun-Young Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Design and Synthesis of New Phthalazinone Derivatives Containing Benzyl Moiety with Anticipated Antitumor Activity
Magda Ismail Marzouk et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Structure-activity relationship study of 4-(thiazol-5-yl)benzoic acid derivatives as potent protein kinase CK2 inhibitors
Hiroaki Ohno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability
Wendy B. Young et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Development of novel proteasome inhibitors based on phthalazinone scaffold
Lingfei Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Synthesis, cytotoxic activity, and tubulin polymerization inhibitory activity of new pyrrol-2(3H)-ones and pyridazin-3(2H)-ones
Samar Hafez Abbas et al.
BIOORGANIC CHEMISTRY (2016)
Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity
Kamilia M. Amin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase
Yang Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The therapeutic journey of pyridazinone
Wasim Akhtar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers
Riham F. George et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl) phthalazine derivatives
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation
Sahar M. Abou-Seri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase
Sebastien L. Degorce et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Anticancer activity assessment of two novel binuclear platinum (II) complexes
Mohammad Bagher Shahsavani et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2016)
Synthesis and antidepressant activity of 5-(benzo[b]furan-2-ylmethyl)-6-methylpyridazin-3(2H)-one derivatives
Youness Boukharsa et al.
MEDICINAL CHEMISTRY RESEARCH (2016)
Cancer anabolic metabolism inhibitors move into clinic
Ken Garber
NATURE BIOTECHNOLOGY (2016)
New pyridazine-based binuclear nickel(II), copper(II) and zinc(II) complexes as prospective anticancer agents
Ummer Muhammed Rafi et al.
NEW JOURNAL OF CHEMISTRY (2016)
Synthesis and Bioevaluation of 3,6-Diaryl-[1,2,4]ltriazolo[4,3-b]Pyridazines as Antitubulin Agents
Qile Xu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Novel PARP inhibitors sensitize human leukemic cells in an endogenous PARP activity dependent manner
Mahesh Hegde et al.
RSC ADVANCES (2016)
Design, synthesis, molecular docking and biological evaluation of imides, pyridazines, and imidazoles derived from itaconic anhydride for potential antioxidant and antimicrobial activities
Prakash S. Nayak et al.
JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE (2016)
Spirooxindoles: Promising scaffolds for anticancer agents
Bin Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Pyridazinone: an important element of pharmacophore possessing broad spectrum of activity
Sonal Dubey et al.
MEDICINAL CHEMISTRY RESEARCH (2015)
PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
Jennine M. Dawicki-McKenna et al.
MOLECULAR CELL (2015)
Olaparib Approved for Advanced Ovarian Cancer
[Anonymous]
CANCER DISCOVERY (2015)
Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4
Julie A. Tucker et al.
STRUCTURE (2014)
Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase
Yoshiko Awazu et al.
CANCER SCIENCE (2013)
dCTP pyrophosphohydrase exhibits nucleic accumulation in multiple carcinomas
Y. Zhang et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2013)
Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors
M. H. G. Langenberg et al.
ANNALS OF ONCOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Are pyridazines privileged structures?
Camille G. Wermuth
MEDCHEMCOMM (2011)
Incorporation of pyridazine rings in the structure of functionalized π-conjugated materials
Sylvain Achelle et al.
RSC ADVANCES (2011)
A Structure-Guided Approach to Creating Covalent FGFR Inhibitors
Wenjun Zhou et al.
CHEMISTRY & BIOLOGY (2010)
Phase I Evaluation of Telatinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Irinotecan and Capecitabine in Patients with Advanced Solid Tumors
Marlies H. G. Langenberg et al.
CLINICAL CANCER RESEARCH (2010)
Tomorrow's targeted therapies in breast cancer patients: What is the risk for increased radiation-induced cardiac toxicity?
Nicolas Magne et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
Dana V. Ferraris
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of 3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant
Wei-Sheng Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: Synthesis and in vitro biological evaluation as potential antitumor agents
Joelle Azema et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Promise and challenges in drug discovery and development of hybrid anticancer drugs
Lalji K. Gediya et al.
EXPERT OPINION ON DRUG DISCOVERY (2009)
Synthesis of New Pyridazine Derivatives as Potential Anti-HIV-1 Agents
Stefania Ferro et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2009)
Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours
Edwina N. Scott et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Current development of clinical inhibitors of poly (ADP-ribose) polymerase in oncology
Kapila Ratnam et al.
CLINICAL CANCER RESEARCH (2007)
20S proteasome and its inhibitors: Crystallographic knowledge for drug development
Ljudmila Borissenko et al.
CHEMICAL REVIEWS (2007)
Principles of mononucleating and binucleating ligand design
AL Gavrilova et al.
CHEMICAL REVIEWS (2004)
分享论文
